autoimmune-diseases

Documents about autoimmune-diseases

• Ultrasound to Detect Splenomegally in Patients With Isolated Thrombocytopenia#840880ClinicalTrials.gov
• Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases#867916ClinicalTrials.gov
• Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases#914642ClinicalTrials.gov
• Biological Activity and Safety of Low Dose IL2 in Relapsing Remitting Multiple Sclerosis#915807ClinicalTrials.gov
• The Role Of Biochemical Parameters In Thyroid Disorders#137298Zenodo (CERN)
• COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders#217105ClinicalTrials.gov
• Functional and dysfunctional T regulatory cell states in human tissues in RA and other autoimmune arthritic diseases#485154Europe PMC
• A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Scleroderma#880565ClinicalTrials.gov
• A Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis#968091ClinicalTrials.gov
• The Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology.#871860ClinicalTrials.gov
• GLP1-E2 therapy delays autoimmune diabetes in late-stage prediabetic NOD mice and potentiates low-dose anti-CD3 therapy for enhanced disease protection#319403Springer Nature OA
• Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study#853317ClinicalTrials.gov
• Coping Strategies, Loneliness, and Resilience in Patients With Dermatosis#888807ClinicalTrials.gov
• Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome#915854ClinicalTrials.gov
• Outcome of patients with autoimmune diseases in the intensive care unit : A mixed cluster analysis#236925Repositorio institucional EdocUR
• Evaluation of the Optimal MTX Dose as an Add-on Therapy to Adalimumab for RA Patients in Japan, South Korea and Taiwan#854232ClinicalTrials.gov
• COVID-19 CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDS#910358ClinicalTrials.gov
• Effectiveness of a Multidisciplinary Treatment and Structured Education Programme#915217ClinicalTrials.gov
• Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia#979461ClinicalTrials.gov
• A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Sjogren's Syndrome#805975ClinicalTrials.gov
• Positron Emission Tomography (PET) to Locate Areas of White Blood Cell Activity#865107ClinicalTrials.gov
• Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases#217044ClinicalTrials.gov
• Características clínicas de pacientes trasplantados renal y hepático con enfermedades reumáticas autoinmunes en LaCardio entre 2018-2024#372350Repositorio institucional EdocUR
• An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases#854779ClinicalTrials.gov
• CHABLIS7.5: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis#912267ClinicalTrials.gov
• Effects of Silica and Asbestos Fibres on the Efferocytosis Capacities of Macrophages#906943ClinicalTrials.gov
• Estimated prevalence, incidence and healthcare costs of Sjögren’s syndrome in France: a national claims-based study#288098HAL (France)
• A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome#830375ClinicalTrials.gov
• Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases#174961ClinicalTrials.gov
• Cohort Study on Neuroimmune Diseases in the Reproductive Age#806933ClinicalTrials.gov
• Realistic in Generation of HEp-2 Cell Images Using Latent Diffusion Models: a Multi-center Visual Turing Test#877503ClinicalTrials.gov
• Comparison of the Efficacy of Clobetasol Propionate 0.05% Mouthwash, Photobiomodulation, and Their Combination in Managing of Oral Lesions in Patient With Pemphigus Vulgaris.#969880ClinicalTrials.gov
• Is it justified to order an upfront cytomegalovirus immunohistochemical stain in patients with severe inflammatory bowel disease and ulceration?#675843eScholarship
• Efficacy and safety of microbiota-targeted therapeutics in autoimmune and inflammatory rheumatic diseases: protocol for a systematic review and meta-analysis of randomised controlled trials#219852Spiral
• Detection and Characterization of Infections and Infection Susceptibility#863298ClinicalTrials.gov
• A Study to Assess CLBR001+SWI019 in Subjects With Autoimmune Diseases#883392ClinicalTrials.gov
• Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases#903079ClinicalTrials.gov
• Hospitalizations for Autoimmune Hepatitis Disproportionately Affect Black and Latino Americans#684053eScholarship
• Quantification and Characterization of Circulating Epithelial and Endothelial Cells in Gougerot-Sjögren Syndrome, Compared to Systemic Sclerosis#905744ClinicalTrials.gov
• A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)#839456ClinicalTrials.gov
• Anti-SSA/Ro positivity and congenital heart block: obstetric and foetal outcome in a cohort of anti-SSA/Ro positive pregnant patients with and without autoimmune diseases#284507IRIS
• Risk factors for immune checkpoint inhibitor colitis: a retrospective multi-center cohort study using electronic health records#620193eScholarship
• Understanding the gastrointestinal microbiome in systemic sclerosis: methodological advancements and emerging research#664944eScholarship